Search Results Search Sort by RelevanceMost Recent Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562. Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551. Case and Commentary Jul 2024 When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond? Taleed El-Sabawi, JD, PhD and Kelly Gillespie, JD, PhD, RN Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements. AMA J Ethics. 2024;26(7):E520-526. doi: 10.1001/amajethics.2024.520. Case and Commentary Jun 2001 Emergency Treatment for Patients Who Cannot Pay Kayhan Parsi, JD, PhD An ethical case explores an emergency physician's refusal to treat an uninsured woman at full term for fear of malpractice. Virtual Mentor. 2001;3(6):183-184. doi: 10.1001/virtualmentor.2001.3.6.hlaw1-0106. Case and Commentary Jul 2001 Is It Covered or Not? Health Plans and Experimental Procedures Kayhan Parsi, JD, PhD An ethical case explores physicians' responsibility to provide quality care to their patients within the limitations of insurance reimbursements. Virtual Mentor. 2001;3(7):224-225. doi: 10.1001/virtualmentor.2001.3.7.hlaw1-0107. Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 1 Amy Haddad, PhD, RN An ethical case explores the costs of prescription drugs and co-pays for patients who can't afford them. Virtual Mentor. 2002;4(11):320-323. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211. Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 2 Audiey Kao, MD, PhD An ethical case explores the costs of prescription drugs and co-pays for patients who can't afford them. Virtual Mentor. 2002;4(11):324-326. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211. Medicine and Society Jul 2024 What Would Equitable Harm Reduction Look Like? Oluwole Jegede, MD, MPH, Julio C. Nunes, MD, Terence Tumenta, MD, MPH, Carmen Black, MD, and Joao P. De Aquino, MD Structural determinants of health frameworks must be person centered and express antiracism to be effective. AMA J Ethics. 2024;26(7):E572-579. doi: 10.1001/amajethics.2024.572. Policy Forum Aug 2024 Why MLP Legal Care Should Be Financed as Health Care William M. Sage, MD, JD and Keegan D. Warren, JD, LLM Expanding MLPs’ positive health impact requires secure funding. AMA J Ethics. 2024;26(8):E640-647. doi: 10.1001/amajethics.2024.640. Case and Commentary Aug 2024 How Should MLP Clinicians and Attorneys Help Veterans Secure Disability Benefits When Health Records Documentation Is Insufficient? Cynthia Geppert, MD, PhD, DPS, MA, MPH, MSB, MSJ, HEC-C MLPs in the VHA help minimize ethical tensions that tend to come up when diagnosing and documenting disability. AMA J Ethics. 2024;26(8):E616-621. doi: 10.1001/amajethics.2024.616. Pagination First page « First Previous page ‹ Previous … Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Current page 21 Page 22 Next page Next › Last page Last »
Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562.
Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551.
Case and Commentary Jul 2024 When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond? Taleed El-Sabawi, JD, PhD and Kelly Gillespie, JD, PhD, RN Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements. AMA J Ethics. 2024;26(7):E520-526. doi: 10.1001/amajethics.2024.520.
Case and Commentary Jun 2001 Emergency Treatment for Patients Who Cannot Pay Kayhan Parsi, JD, PhD An ethical case explores an emergency physician's refusal to treat an uninsured woman at full term for fear of malpractice. Virtual Mentor. 2001;3(6):183-184. doi: 10.1001/virtualmentor.2001.3.6.hlaw1-0106.
Case and Commentary Jul 2001 Is It Covered or Not? Health Plans and Experimental Procedures Kayhan Parsi, JD, PhD An ethical case explores physicians' responsibility to provide quality care to their patients within the limitations of insurance reimbursements. Virtual Mentor. 2001;3(7):224-225. doi: 10.1001/virtualmentor.2001.3.7.hlaw1-0107.
Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 1 Amy Haddad, PhD, RN An ethical case explores the costs of prescription drugs and co-pays for patients who can't afford them. Virtual Mentor. 2002;4(11):320-323. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211.
Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 2 Audiey Kao, MD, PhD An ethical case explores the costs of prescription drugs and co-pays for patients who can't afford them. Virtual Mentor. 2002;4(11):324-326. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211.
Medicine and Society Jul 2024 What Would Equitable Harm Reduction Look Like? Oluwole Jegede, MD, MPH, Julio C. Nunes, MD, Terence Tumenta, MD, MPH, Carmen Black, MD, and Joao P. De Aquino, MD Structural determinants of health frameworks must be person centered and express antiracism to be effective. AMA J Ethics. 2024;26(7):E572-579. doi: 10.1001/amajethics.2024.572.
Policy Forum Aug 2024 Why MLP Legal Care Should Be Financed as Health Care William M. Sage, MD, JD and Keegan D. Warren, JD, LLM Expanding MLPs’ positive health impact requires secure funding. AMA J Ethics. 2024;26(8):E640-647. doi: 10.1001/amajethics.2024.640.
Case and Commentary Aug 2024 How Should MLP Clinicians and Attorneys Help Veterans Secure Disability Benefits When Health Records Documentation Is Insufficient? Cynthia Geppert, MD, PhD, DPS, MA, MPH, MSB, MSJ, HEC-C MLPs in the VHA help minimize ethical tensions that tend to come up when diagnosing and documenting disability. AMA J Ethics. 2024;26(8):E616-621. doi: 10.1001/amajethics.2024.616.